Skip to content

Clinical trials

Completed Phase 2 Cardiomyopathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathies Phase: Phase 2 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20081
20124
20141
20151
20161
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Capricor Inc.2
Alnylam Pharmaceuticals1
Annetine Gelijns1
Bayer1
Celladon Corporation1
Daiichi Sankyo1
Deborah Ascheim1
Heidi Moretti, MS, RD1
National Heart, Lung, and Blood Institute (NHLBI)1
Omeicos Therapeutics GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathies14
Heart Failure6
Heart Diseases2
Muscular Dystrophy, Duchenne2
Ventricular Dysfunction2
Acidosis, Lactic1
Adenoviridae Infections1
Alzheimer Disease1
Cardiomegaly1
Cardiomyopathy, Hypertrophic1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.